CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
CollimateHealth has raised $6.9M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
CollimateHealth's investors include HTGF (High-Tech Gruenderfonds), XISTA Science Ventures, Caesar Ventures, VP Venture Partners, Positron Ventures.
CollimateHealth is headquartered in München, Germany.
CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
CollimateHealth is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CollimateHealth — Funding & Investors." VCBacked, June 12, 2026, https://www.vcbacked.co/company/collimatehealth. Accessed August 23, 2026.
VCBacked. (2026). CollimateHealth — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/collimatehealth
{{cite web |title=CollimateHealth — Funding & Investors |url=https://www.vcbacked.co/company/collimatehealth |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated